FDA grants Tentative Approval for Yutrepia to treat pulmonary arterial hypertension – Liquidia Corpn
Liquidia Corporation has announced that the FDA granted tentative approval for Yutrepia (treprostinil) inhalation powder, previously referred to as LIQ 861. Yutrepia is indicated for the treatment of… read more.
